Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1
ConclusionCAS effectively inhibits stemness in CCSLCs through suppression of DNMT1 activation, suggesting that CAS acts as a promising preventive and therapeutic candidate in cervical cancer.
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | China Health | Internal Medicine | Nanotechnology | Stem Cell Therapy | Stem Cells